Jay Stout
Technik-/Wissenschafts-/F&E-Leiter bei IMMUNOVANT, INC.
Vermögen: 4 Mio $ am 30.04.2024
Profil
Jay Stout is currently the Chief Technology Officer at Immunovant, Inc. He previously worked as the Chief Technical Officer at Immunomedics, Inc. and as the Senior Vice President-Technical Operations at Versartis, Inc. Stout received his undergraduate and graduate degrees from the University of Iowa and his doctorate from The University of Nebraska-Lincoln.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IMMUNOVANT INC
0,10% | 24.04.2024 | 147 739 ( 0,10% ) | 4 Mio $ | 30.04.2024 |
Aktive Positionen von Jay Stout
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNOVANT, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2023 |
Ehemalige bekannte Positionen von Jay Stout
| Unternehmen | Position | Ende |
|---|---|---|
| IMMUNOMEDICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Jay Stout
| The University of Nebraska-Lincoln | Doctorate Degree |
| University of Iowa | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IMMUNOVANT, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Health Technology |
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
